{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:02:38Z","timestamp":1792242158352,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018925","name":"Health Commission of Henan Province","doi-asserted-by":"publisher","award":["LHGJ20230161"],"award-info":[{"award-number":["LHGJ20230161"]}],"id":[{"id":"10.13039\/100018925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016305","name":"The First Affiliated Hospital of Zhengzhou University","doi-asserted-by":"publisher","award":["ZYCXTD202310"],"award-info":[{"award-number":["ZYCXTD202310"]}],"id":[{"id":"10.13039\/501100016305","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404424"],"award-info":[{"award-number":["82404424"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bmc.2025.118415","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T08:07:24Z","timestamp":1758701244000},"page":"118415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Optimization of novel TRPV1 antagonists bearing 1-((2,2-difluorobenzo[d][1,3] dioxol-5-yl) methyl) piperazine for pain management: Mechanistic insights into NLRP3 Inflammasome modulation"],"prefix":"10.1016","volume":"131","author":[{"given":"Chunxia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyang","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118415_bb0005","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41422-022-00616-y","article-title":"Inhibiting Hv1 channel in peripheral sensory neurons attenuates chronic inflammatory pain and opioid side effects","volume":"32","author":"Zhang","year":"2022","journal-title":"Cell Res"},{"key":"10.1016\/j.bmc.2025.118415_bb0010","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41392-023-01464-x","article-title":"TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.bmc.2025.118415_bb0015","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/s41419-021-04450-9","article-title":"TRPV1 channel mediates NLRP3 inflammasome-dependent neuroinflammation in microglia","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.bmc.2025.118415_bb0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41573-021-00268-4","article-title":"Advances in TRP channel drug discovery: from target validation to clinical studies","volume":"21","author":"Koivisto","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2025.118415_bb0025","article-title":"NLRP3 upregulation related to sleep deprivation-induced memory and emotional behavior changes in TRPV1 mice","volume":"440","author":"Ahsawle Ozathaley","year":"2023","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bmc.2025.118415_bb0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/cells11010018","article-title":"Capsaicin and TRPV1 channels in the cardiovascular system: the role of inflammation","volume":"11","author":"Munjuluri","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bmc.2025.118415_bb0035","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41586-022-05570-8","article-title":"Cryo-EM structures of the active NLRP3 inflammasome disc","volume":"613","author":"Xiao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2025.118415_bb0040","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1038\/s41590-023-01656-1","article-title":"E-selectin-mediated rapid NLRP3 inflammasome activation regulates S100A8\/S100A9 release from neutrophils via transient gasdermin D pore formation","volume":"24","author":"Pruenster","year":"2023","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bmc.2025.118415_bb0045","doi-asserted-by":"crossref","first-page":"1137822","DOI":"10.3389\/fimmu.2023.1137822","article-title":"Role of NLRP3 in the pathogenesis and treatment of gout arthritis","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmc.2025.118415_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.931690","article-title":"Role of NLRP3 Inflammasome in rheumatoid arthritis","volume":"13","author":"Yin","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmc.2025.118415_bb0055","doi-asserted-by":"crossref","first-page":"2163838","DOI":"10.1080\/19490976.2022.2163838","article-title":"An IBD-associated pathobiont synergises with NSAID to promote colitis which is blocked by NLRP3 inflammasome and Caspase-8 inhibitors","volume":"15","author":"Singh","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.bmc.2025.118415_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.837977","article-title":"BRD4 inhibition attenuates inflammatory pain by ameliorating NLRP3 Inflammasome-induced Pyroptosis","volume":"13","author":"Hua","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmc.2025.118415_bb0065","article-title":"Dimethyl Itaconate attenuates CFA-induced inflammatory pain via the NLRP3\/ IL-1\u03b2 signaling pathway","volume":"13","author":"Lin","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmc.2025.118415_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114893","article-title":"Research progress and challenges of TRPV1 channel modulators as a prospective therapy for diabetic neuropathic pain","volume":"245","author":"Liu","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118415_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115806","article-title":"Progress in the development of TRPV1 small-molecule antagonists: novel strategies for pain management","volume":"261","author":"Zhu","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118415_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117649","article-title":"Structure optimization of natural product piperine to obtain novel and potent analogs with anti-inflammation pain and urate-lowering effect","volume":"292","author":"Liu","year":"2025","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118415_bb0085","doi-asserted-by":"crossref","first-page":"11658","DOI":"10.1021\/acs.jmedchem.2c00469","article-title":"Discovery of potent and selective transient receptor potential Vanilloid 1 (TRPV1) agonists with analgesic effects in vivo based on the functional conversion induced by altering the orientation of the Indazole Core","volume":"65","author":"Liang","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118415_bb0090","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1515\/sjpain-2018-0103","article-title":"Effect of the market withdrawal of dextropropoxyphene on use of other prescribed analgesics","volume":"18","author":"Reset","year":"2018","journal-title":"Scand J Pain"},{"key":"10.1016\/j.bmc.2025.118415_bb0095","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/FJC.0b013e31818eec8d","article-title":"Clemens Mo\u00a8ller, effects of common antitussive drugs on the hERG Potassium Channel current","volume":"52","author":"Deisemann","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.bmc.2025.118415_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112290","article-title":"hERG toxicity assessment: useful guidelines for drug design","volume":"195","author":"Garrido","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118415_bb0105","doi-asserted-by":"crossref","first-page":"14447","DOI":"10.1021\/acs.jmedchem.3c01370","article-title":"Recent Progress and prospects of small molecules for NLRP3 Inflammasome inhibition","volume":"66","author":"Li","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118415_bb0110","doi-asserted-by":"crossref","first-page":"16141","DOI":"10.1021\/acs.jmedchem.3c01511","article-title":"Discovery of novel 2,3-Dihydro-1H-indene-5-sulfonamide NLRP3 Inflammasome inhibitors targeting Colon as a potential therapy for colitis","volume":"66","author":"Sun","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118415_bb0115","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/s41401-023-01054-1","article-title":"Atranorin inhibits NLRP3 inflammasome activation by targeting ASC and protects NLRP3 inflammasome-driven diseases","volume":"44","author":"Wang","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.bmc.2025.118415_bb0120","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and regulation of the inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bmc.2025.118415_bb0125","doi-asserted-by":"crossref","first-page":"9279","DOI":"10.1021\/acs.jmedchem.4c02883","article-title":"Development of hydrazide-based HDAC6 selective inhibitors for treating NLRP3 Inflammasome-related diseases","volume":"68","author":"Yue","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118415_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108788","article-title":"N-substituted phthalimide\u2013carboxylic acid hybrids as dual-targeted aldose reductase inhibitors: synthesis, mechanistic insights, and cancer-relevant profiling","volume":"163","author":"Zognjani","year":"2025","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118415_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108689","article-title":"Fluorenyl-phthalimide hybrids as potent aldose reductase inhibitors with selective anticancer activity: rational design, synthesis, and molecular insights","volume":"163","author":"Gundogdu","year":"2025","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118415_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108861","article-title":"Chalcone-inspired indole, carbazole, and phenothiazine hybrids as potent aldose reductase inhibitors with selective anticancer potential: rational design, synthesis, and multi-level characterization","volume":"164","author":"G\u00fcle\u00e7","year":"2025","journal-title":"Bioorg Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625003566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625003566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:32:45Z","timestamp":1780403565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625003566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":28,"alternative-id":["S0968089625003566"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118415","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of novel TRPV1 antagonists bearing 1-((2,2-difluorobenzo[d][1,3] dioxol-5-yl) methyl) piperazine for pain management: Mechanistic insights into NLRP3 Inflammasome modulation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118415"}}